Vaxcyte, Inc. — Director's Dealing 2024

Oct 30, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2024-10-28

Reporting Person: Wassil Jim (CHIEF OPERATING OFFICER)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-10-28	Common Stock	M	1585	$5.35	Acquired	202231	Direct
2024-10-28	Common Stock	M	3464	$20.93	Acquired	205695	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-10-28	Stock Option (right to buy)	$5.35	M	1585	Disposed	2030-04-17	Common Stock (1585)	Direct
2024-10-28	Stock Option (right to buy)	$20.93	M	3464	Disposed	2031-03-31	Common Stock (3464)	Direct

Footnotes

F1: Shares are subject to the restrictions on transfer set forth in a Lock-Up Agreement dated September 4, 2024.

F2: Stock Option is fully vested and exercisable.

F3: 1/48 of the shares subject to the option vested on May 1, 2021, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date.